Dan A. Dixon

This paper shows Eltanexor, an XPO1 inhibitor, reduces COX-2 and Wnt/β-catenin signaling in CRC, decreasing tumor burden in Apcmin/+ mice.

This study shows Rab27B deletion impairs autophagy flux in CRC cells, reduces tumor growth, and prevents spheroid formation.